FDA Investigator Jon P Antoniou
Jon P Antoniou has conducted inspections on 16 sites in 1 countries as of 07 Apr 2021. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
07 Apr 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jon P Antoniou:
Alan L Truong,
Amanda M Dunneback,
Andrew J Barrowcliff,
Anna M Brannen,
Bei Y He,
Bethany L Subel,
Byeongtaek Oh,
Charles Yuanchia Kuo, PhD,
Christina Capacci Daniel, PhD,
Christina L Bigham,
Christine E Kelley,
Christopher T Middendorf,
Cristina Ausin Moreno, PhD,
Cynthia T Cain,
D Yvette Barnett,
David P Moorhead,
David S Jackson,
Diane L Raccasi,
Donna F Campbell,
Dyvette Arline,
Eboni S Funderburk,
Edwin Jao,
Elisa A Nickum,
Elisa A Weckerling,
Elizabeth L Loreaux,
Elizabeth Ll Edwards,
Emilie E Kahn,
Esther C Broner, PhD,
Genevieve E Ghand,
Gerard T Schneider,
Heather A Mccauley,
Hyung Yul Lee,
Isabel Y Espinosa,
Jacob G Lutz,
James A Lane,
James Norman,
Jamie L Dion,
Javonica F Penn,
Jeffrey D Meng,
Jennifer L Gustavus,
Jill R Loeliger,
Jill R Raezer,
Joshua P Wireman,
Joshua S Hunt,
Joslyn K Brunelle, PhD,
Kathleen D Culver,
Kenneth E Felkley,
Lauren N Howard,
Lauren N Smith,
Lauren R Collins,
LCDR Sean Byrd,
Lindsey M Schwierjohann,
Lisa R Hilliar,
Logan T Williams,
Mantai Z Mesmer,
Maria Cruz Fisher,
Marianne Allen,
Maribeth G Grattan,
Mark E Parmon,
Meisha R Sampson,
Meisha Waters,
Michael P Sheehan,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Muna Algharibeh,
Nicholas L Paulin,
Nina Ni,
Paranthaman Senthamaraikannan,
Pifer,
Rabia Ballica, PhD,
Rafeeq A Habeeb,
Robert Barbosa,
Robert M Barbosa,
Roy C Stephens,
Sandra A Boyd,
Sargum C Sood,
Scott R Nichols, PhD,
Shannon D Fink,
Shannon F Underwood,
Sneha S Patel,
Steven P Eastham,
Sydney S Choi,
Talmane J Fisher,
Tamara M Kays,
Tarun D Mehta,
Teresa K Kastner,
Thomas J Arista,
Thomas W Nojek,
Timothy J Schmidt,
Tracey L Harris,
Vaishali J Patel,
Wayne E Seifert,
Wen Ning Chan (Sally),
Wendy G Tan, PhD,
Yanming An, PhD,
Ying Zhang,
Yuan Chia Kuo,
Yvette Mlacour Davis
Jon P Antoniou's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more